The leading open access journal in the field of neurosciences, Molecular Neurodegeneration encompasses all aspects of neurodegeneration research at the molecular and cellular levels.
- Guojun Bu, Mayo Clinic, USA
- Huaxi Xu, Sanford Burnham Prebys Medical Discovery Institute, USA
News from Alzforum
Molecular Neurodegeneration is the official journal of the BrightFocus Foundation.
Annual Journal Metrics
45 days to first decision for reviewed manuscripts only
32 days to first decision for all manuscripts
139 days from submission to acceptance
15 days from acceptance to publication
494 Altmetric mentions